Y-mAbs Therapeutics, Inc. Inventory Write-down
Y-mAbs Therapeutics, Inc. reported Inventory Write-down of $0 for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2025-08-08
- Y-mAbs Therapeutics, Inc. inventory write-down for the quarter ending 2025-06-30 was $0.00.
- Y-mAbs Therapeutics, Inc. inventory write-down for the quarter ending 2024-12-31 was $578.00K.
- Y-mAbs Therapeutics, Inc. inventory write-down for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- Y-mAbs Therapeutics, Inc. inventory write-down for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- Y-mAbs Therapeutics, Inc. inventory write-down for fiscal 2024 was $578.00K, a 30.45% decline from fiscal 2023.
- Y-mAbs Therapeutics, Inc. inventory write-down for fiscal 2023 was $831.00K, a 30.75% decline from fiscal 2022.
- Y-mAbs Therapeutics, Inc. inventory write-down for fiscal 2022 was $1.20M.
- Y-mAbs Therapeutics, Inc. inventory write-down for fiscal 2021 was $0.00.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month |
|---|---|---|---|---|
| 2025-06-30 | $0.00 10-Q · filed 2025-08-08 | $0.00 10-Q · filed 2025-08-08 | ||
| 2024-12-31 | $578.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $578.00K derived: sum of 2 quarters · filed 2025-03-04 | $578.00K derived: sum of 3 quarters · filed 2025-08-08 | $578.00K 10-K · filed 2025-03-04 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-08 | $0.00 derived: sum of 2 quarters · filed 2025-08-08 | $0.00 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-08 | $0.00 10-Q · filed 2025-08-08 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $375.00K derived: sum of 2 quarters · filed 2025-03-04 | $831.00K derived: sum of 3 quarters · filed 2025-03-04 | $831.00K 10-K · filed 2025-03-04 |
| 2023-09-30 | $375.00K 10-Q · filed 2024-11-08 | $831.00K derived: sum of 2 quarters · filed 2024-11-08 | $831.00K 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $456.00K 10-Q · filed 2024-08-12 | $456.00K 10-Q · filed 2024-08-12 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $1.20M derived: sum of 2 quarters · filed 2024-02-29 | $1.20M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $1.20M 10-Q · filed 2023-11-13 | $1.20M 10-Q · filed 2023-11-13 | ||
| 2021-12-31 | $0.00 10-K · filed 2022-03-01 | |||
| 2021-03-31 | $0.00 10-Q · filed 2021-05-06 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-03-01 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-03-01 |